6th Jul 2021 15:52
Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Chief Business Officer Jason Slingsby exercises nil-cost options for 1,584 shares and sells all of them for 1,298.5 pence each, worth GBP20,569, on Friday last week.
Current stock price: 1,326.52p
Year-to-date change: up 29%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica